Please login to the form below

Not currently logged in
Email:
Password:

PrEP

This page shows the latest PrEP news and features for those working in and with pharma, biotech and healthcare.

EMA launches rolling review of J&J’s COVID-19 vaccine

EMA launches rolling review of J&J’s COVID-19 vaccine

J&J is also in talks with other global health regulatory authorities as it preps regulatory review processes for the COVID-19 vaccine to be used during the pandemic response period.

Latest news

More from news
Approximately 3 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Redefining communications excellence Redefining communications excellence

    In 2016, Gilead broke its self-enforced moratorium on the marketing of Truvada for PrEP, its drug for preventing HIV. ... A survey run in 2014 and 2015 found two-thirds of primary care physicians had never discussed Truvada for PrEP with their patients.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • World AIDS Day 2018: Fighting the stigma surrounding HIV

    14. Both pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) drugs may prevent infection developing. ... PrEP (pre-exposure prophylaxis). Available at: . Accessed November 2018. NHS. Can post-exposure prophylaxis (PEP) stop me getting HIV?

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics